Cargando…

Advances of Zinc Signaling Studies in Prostate Cancer

Prostate cancer (PCa) is one of the most common cancers and the second leading cause of cancer-related death among men worldwide. Despite progresses in early diagnosis and therapeutic strategies, prognosis for patients with advanced PCa remains poor. Noteworthily, a unique feature of healthy prostat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Dangdang, Stovall, Daniel B., Wang, Wenmeng, Sui, Guangchao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7014440/ https://www.ncbi.nlm.nih.gov/pubmed/31963946 http://dx.doi.org/10.3390/ijms21020667

Ejemplares similares

Phase-Separated Subcellular Compartmentation and Related Human Diseases
por: Zhang, Lin, et al.
Publicado: (2022)

YY1 Oligomerization Is Regulated by Its OPB Domain and Competes with Its Regulation of Oncoproteins
por: Qiao, Shiyao, et al.
Publicado: (2022)

Disruption of YY1-EZH2 Interaction Using Synthetic Peptides Inhibits Breast Cancer Development
por: Yi, Cheng, et al.
Publicado: (2021)

A histidine cluster determines YY1-compartmentalized coactivators and chromatin elements in phase-separated enhancer clusters
por: Wang, Wenmeng, et al.
Publicado: (2022)

Integrative genomic analyses of promoter G-quadruplexes reveal their selective constraint and association with gene activation
por: Li, Guangyue, et al.
Publicado: (2023)

SOX7 Target Genes and Their Contribution to Its Tumor Suppressive Function
por: Zhang, Yumeng, et al.
Publicado: (2018)

Small Molecule Compounds of Natural Origin Target Cellular Receptors to Inhibit Cancer Development and Progression
por: Wang, Jinhua, et al.
Publicado: (2022)

Emerging Roles of LncRNAs in the EZH2-regulated Oncogenic Network
por: Hao, Aixin, et al.
Publicado: (2021)

Thymoquinone Selectively Induces Hepatocellular Carcinoma Cell Apoptosis in Synergism With Clinical Therapeutics and Dependence of p53 Status
por: Jehan, Shah, et al.
Publicado: (2020)

Polydatin Inhibits Hepatocellular Carcinoma Cell Proliferation and Sensitizes Doxorubicin and Cisplatin through Targeting Cell Mitotic Machinery
por: Farooq, Umar, et al.
Publicado: (2023)

Mechanisms regulating DMTF1β/γ expression and their functional interplay with DMTF1α
por: Li, Jialiang, et al.
Publicado: (2020)

Growth Modulatory Role of Zinc in Prostate Cancer and Application to Cancer Therapeutics
por: To, Phuong Kim, et al.
Publicado: (2020)

From General Aberrant Alternative Splicing in Cancers and Its Therapeutic Application to the Discovery of an Oncogenic DMTF1 Isoform
por: Tian, Na, et al.
Publicado: (2017)

The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots
por: Costello, Leslie C, et al.
Publicado: (2006)

Loss and revival of androgen receptor signaling in advanced prostate cancer
por: Formaggio, Nicolò, et al.
Publicado: (2021)

Biomarkers for Prostate Cancer Bone Metastasis Detection and Prediction
por: Ying, Mingshuai, et al.
Publicado: (2023)

Noncoding RNA in Oncogenesis: A New Era of Identifying Key Players
por: Deng, Guorui, et al.
Publicado: (2013)

Dietary Phytochemicals in Zinc Homeostasis: A Strategy for Prostate Cancer Management
por: Singh, Chandra K., et al.
Publicado: (2021)

Zinc Signals and Immunity
por: Maywald, Martina, et al.
Publicado: (2017)

Zinc in Cellular Regulation: The Nature and Significance of “Zinc Signals”
por: Maret, Wolfgang
Publicado: (2017)

Advances in prostate cancer imaging
por: Tangel, Matthew R., et al.
Publicado: (2018)

Advances in breeding for high grain Zinc in Rice
por: Swamy, B. P. Mallikarjuna, et al.
Publicado: (2016)

Zinc in Prostate Health and Disease: A Mini Review
por: Karunasinghe, Nishi
Publicado: (2022)

Zinc Signal in Brain Diseases
por: Portbury, Stuart D., et al.
Publicado: (2017)

Recent advances in prostate cancer: WNT signaling, chromatin regulation, and transcriptional coregulators
por: Takahashi, Sayuri, et al.
Publicado: (2023)

hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer
por: Franklin, Renty B, et al.
Publicado: (2005)

Analysis of Zinc-Exporters Expression in Prostate Cancer
por: Singh, Chandra K., et al.
Publicado: (2016)

Recent Advances in Zinc Oxide Nanostructures with Antimicrobial Activities
por: Li, Yuchao, et al.
Publicado: (2020)

Sipuleucel-T: immunotherapy for advanced prostate cancer
por: Olson, Brian M, et al.
Publicado: (2011)

Advances in PARP Inhibitors for Prostate Cancer
por: Tisseverasinghe, Steven, et al.
Publicado: (2023)

Response to commentary “Zinc is decreased in prostate cancer: an established relationship of prostate cancer!”
por: Banas, Agnieszka Maria, et al.
Publicado: (2010)

Novel Redirected T–Cell Immunotherapies for Advanced Prostate Cancer
por: Dorff, Tanya B., et al.
Publicado: (2022)

Advances in (177)Lu-PSMA and (225)Ac-PSMA Radionuclide Therapy for Metastatic Castration-Resistant Prostate Cancer
por: Ling, Sui Wai, et al.
Publicado: (2022)

Clinical Implications of Hedgehog Pathway Signaling in Prostate Cancer
por: Suzman, Daniel L., et al.
Publicado: (2015)

Overcoming Immune Resistance in Prostate Cancer: Challenges and Advances
por: Movassaghi, Miyad, et al.
Publicado: (2021)

Recent advances in dynamic m(6)A RNA modification
por: Cao, Guangchao, et al.
Publicado: (2016)

Positive and Negative Regulation of Prostate Stem Cell Antigen Expression by Yin Yang 1 in Prostate Epithelial Cell Lines
por: Tang, Shuai, et al.
Publicado: (2012)

Dietary Zinc and Risk of Prostate Cancer in Spain: MCC-Spain Study
por: Gutiérrez-González, Enrique, et al.
Publicado: (2018)

Fatty Acid Metabolism Reprogramming in Advanced Prostate Cancer
por: Xu, Huan, et al.
Publicado: (2021)

Caffeic Acid Phenethyl Ester as a Potential Treatment for Advanced Prostate Cancer Targeting Akt Signaling
por: Lin, Hui-Ping, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_uiacmh5c30a9l77175oeisjpci